Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma. This evidence concerns the gene EGLN3 and clear cell renal carcinoma.